Search

everythinglearnresearchcommunity

for

Search:↓

TFC-loaded microneedles effectively promote hair regrowth in androgenetic alopecia.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

The Itpr3 gene causes a specific hair pattern in mice.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

FER and TOR signaling help root hair growth in low temperature and low nitrate conditions.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

NFAT5 triggers atherosclerosis under stress by activating inflammation in blood vessels.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

TNF-a may not be as involved in certain types of hair loss as previously thought.

NFATc1 controls hair stem cell activity, affecting hair growth and could be a target for hair loss treatments.

Tofacitinib taken by mouth helps treat hair loss in children.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

IPL treatment can significantly reduce hair in faun tail but may need local anesthesia.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Intense Pulse Light effectively reduces hair growth in faun tail nevus.

The pseudo 'fringe sign' can also appear in frontal fibrosing alopecia, not just in traction alopecia, showing that this condition may be more common than thought.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.